Literature DB >> 8438472

Prolongation of allogeneic transplanted skin grafts and induction of tolerance by leflunomide, a new immunosuppressive isoxazol derivative.

H U Schorlemmer1, F R Seiler, R R Bartlett.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8438472

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  6 in total

1.  Inhibition of murine IgE and immediate cutaneous hypersensitivity responses to ovalbumin by the immunomodulatory agent leflunomide.

Authors:  E R Jarman; A Kuba; E Montermann; R R Bartlett; A B Reske-Kunz
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

Review 2.  Xenobiotics, chimerism and the induction of tolerance following organ transplantation.

Authors:  C P Delaney; A W Thomson; A J Demetris; T E Starzl
Journal:  Ther Immunol       Date:  1994-06

Review 3.  Leflunomide: mode of action in the treatment of rheumatoid arthritis.

Authors:  F C Breedveld; J M Dayer
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

4.  Leflunomide interferes with pyrimidine nucleotide biosynthesis.

Authors:  H M Cherwinski; N Byars; S J Ballaron; G M Nakano; J M Young; J T Ransom
Journal:  Inflamm Res       Date:  1995-08       Impact factor: 4.575

5.  Leflunomide therapy following penetrating keratoplasty in the rat.

Authors:  S E Coupland; S Klebe; A C Karow; L Krause; H Kruse; R R Bartlett; F Hoffmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-10       Impact factor: 3.117

6.  Prevention of the acute graft-versus-host disease (GVHD) in rats by the immunomodulating drug leflunomide.

Authors:  C Mrowka; G H Thoenes; K H Langer; R R Bartlett
Journal:  Ann Hematol       Date:  1994-04       Impact factor: 3.673

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.